Abstract B116: Preclinical characterization of orally bioavailable, highly potent pan-KRAS inhibitors with selectivity over HRAS and NRAS von Vallejo, Lourdes Prieto, Iyer, Chandrasekar, Goggin, Noelle, Li, Binghui, Yang, Peiyi, Bian, Huimin, Podoll, Jessica, Grotegut, Stefan, Tandon, Manuj, Anderson, Bryan D, Capen, Andrew, Xiao, Min, Wang, Tao, Stewart, Trent R, Aronow, Sean, Bume, Desta, Garcia, Isabel Rojo, Si, Chong, Cooke, Andrew, Bondi, Robert, Kelamangalath, Lakshmi, Wallace, Ross, Kolakowski, Gabrielle, LeBrun, Lauire, Henry, James R, Kercher, Tim

Volltext